Macquarie Group
TRHC

Macquarie Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Macquarie Group’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,372,927
Closed -$7.91K – 2645
2022
Q1 		$7.91K Sell
1,372,927
-409,365
-23% -$3.67M 0.01% 990
2021
Q4 		$26.7M Sell
1,782,292
-878,307
-33% -$16M 0.02% 680
2021
Q3 		$69.7M Buy
2,660,599
+10,076
+0.4% +$371K 0.06% 423
2021
Q2 		$133M Buy
2,650,523
+1,318,103
+99% +$59M 0.11% 231
2021
Q1 		$61.4M Buy
1,332,420
+35,576
+3% +$1.7M 0.09% 285
2020
Q4 		$55.6M Sell
1,296,844
-43,023
-3% -$1.63M 0.08% 289
2020
Q3 		$54.6M Buy
1,339,867
+137,375
+11% +$6.84M 0.09% 240
2020
Q2 		$65.8M Buy
1,202,492
+81,786
+7% +$4.68M 0.11% 193
2020
Q1 		$58.6M Buy
1,120,706
+118,410
+12% +$6.41M 0.12% 164
2019
Q4 		$48.8M Buy
1,002,296
+227,187
+29% +$10.6M 0.07% 301
2019
Q3 		$42.6M Buy
775,109
+47,082
+6% +$2.69M 0.07% 290
2019
Q2 		$36.4M Buy
728,027
+151,779
+26% +$7.55M 0.06% 326
2019
Q1 		$32.5M Buy
576,248
+260,208
+82% +$15.5M 0.06% 355
2018
Q4 		$20.2M Buy
316,040
+295,233
+1,419% +$20.9M 0.04% 427
2018
Q3 		$1.69M Sell
20,807
-2,968
-12% -$217K ﹤0.01% 1054
2018
Q2 		$1.52M Sell
23,775
-3,119
-12% -$153K ﹤0.01% 1077
2018
Q1 		$1.04M Buy
26,894
+592
+2% +$20.7K ﹤0.01% 1169
2017
Q4 		$738K Buy
+26,302
New +$771K ﹤0.01% 1331

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Macquarie Group's TRHC Position: Q2 2022 in Review

Macquarie Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 1,372,927 shares — an estimated $7.91K sold.

Macquarie Group first reported a position in TRHC in Q4 2017 and held it in 18 quarters. The position peaked at $133M in Q2 2021. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Macquarie Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Macquarie Group sold 1,372,927 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $7.91K.
  • Macquarie Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 18 quarters.
  • Macquarie Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $133M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.